| Study Period | 2019 - 2032 |
| 2024 Market Size | USD 7.6 Billion |
| 2025 Market Size | USD 8.2 Billion |
| 2032 Forecast | USD 14.5 Billion |
| Growth Rate(CAGR) | 8.4% |
| Largest Region | North America |
| Fastest Growing Region | APAC |
| Nature of the Market | Fragmented |
| Largest End User Category | Hospitals |
|
Explore the market potential with our data-driven report
The medication management market size stood at USD 7.6 billion in 2024, and it is expected to grow at a CAGR of 8.4% during 2025–2032, to reach USD 14.5 billion by 2032. The demand for software and services for medication management is extensively growing by the increasing geriatric population, the surging need to cut medical care expenditures, the high incidence of chronic illnesses, and improved Medicare services.
Moreover, players in the healthcare sector have increased investments to improve workflow, rapid and advanced development of medical technology, and greater emphasis on lowering prescription errors. Thus, investments in healthcare information technology (HIT) gained a high pace, along with other government measures, which have increased the adoption rate of drug distribution systems globally.
Over the course of the forecast period, the demand will increase, as a result of the widespread adoption of IT in the medical care industry. The COVID-19 epidemic had a favorable effect on the market. Patients with chronic illnesses could not access medical centers for standard care and prescription administration. Retail and online pharmacies provided emergency services to patients with convenient and rapid access. The participation of community pharmacists at hospitals’ outdoor centers during the pandemic required a strict inventory of drugs, where such software and control systems helped in easing the pressure on the overloaded medical handling systems.
The IT sector for healthcare software and services also benefited from strategies adopted by players such as mergers and acquisitions. For instance, McKesson Corporation acquired OncoHealth and Prescribing Support Services in May 2022. Also, the company made investments in a number of sectors, such as healthcare IT, pharmacy IT, and life sciences platforms and tools. The usage of medicine distribution control software is being encouraged by the shortage of pharmacists and primary-care workers in order to improve workflow.
Massive unexplored drug control medication management markets across the globe have created abundant opportunities for major players. With the significant development in emerging economies, the demand for drug distribution systems is expected to increase rapidly in the coming years. Also, the high growth in the end-user categories, such as hospitals and pharmacies, has been witnessed in developing nations. This provides immense growth opportunities for players offering medicine management solutions.
Hospitals are the largest end users of medicine control systems, accounting for a share 60% in 2024, and they will also witness the fastest growth. This is because, in recent years, hospitals have begun making significant financial investments in the adoption and modernization of their IT systems. Also, healthcare organizations are concentrating on enhancing workflow effectiveness, safely delivering medication, and streamlining intricate clinical procedures.
In addition, the pharmacies category is expected to witness significant growth in the coming years. Some of the major causes of the expansion of management solutions in pharmacies are a surge in the number of prescriptions due to the increased burden of chronic and infectious diseases, and the lack of pharmacists. The implementation of automated pharmacy systems is projected to reduce the workload for pharmacists and help them manage patient prescriptions effectively. Thus, with the rise in cases of infectious and chronic diseases and the increase in the number of prescriptions written, pharmacies will become more prominent in the market.
We studied these end users:
In 2024, the cloud category dominated the market, and it will witness the highest CAGR of 10%. For simple information exchange with clients and other stakeholders, a number of firms are offering cloud-based deployment solutions. The need for commercially available cloud solutions is likely to be significantly influenced by the ease with which information may be accessed in remote locations using such solutions. In addition, the demand is projected to grow in the coming years, due to the emphasis on patient data privacy and the adoption of regulations related to it.
Moreover, due to several security flaws in web-based and on-premises deployment, cloud-based technology deployment is gaining rapid popularity. Cloud service providers also offer solutions that address different threats and protect against data loss and theft. As a result, the category leads the market.
These modes of delivery have been considered:
The CPOE category dominated the market in 2024 with 45% share. This is attributed to the rising need to enhance patient safety and operational speed and efficiency, as well as improving communication. The data collected and utilized by this software also improves cost-efficiency in operations, regulatory compliance, and record-keeping. CPOE is an application that enables healthcare professionals to input medical orders into a computer system, which is located within an inpatient setting. It has replaced traditional methods of placing medication orders, such as paper-based prescriptions, and verbal transcripts. Most CPOE systems allow healthcare providers to electronically specify medication orders, as well as admission procedures, and laboratory tests.
The CDSS category will witness the highest CAGR during the forecast period. CDSS is an application that helps healthcare professionals in analyzing medical information including medication related data, and assists them in making clinical decisions in healthcare planning.
Healthcare professionals, including doctors, and nurses use CDSS software to prepare a complete diagnosis plan; and further review the plan in management of diseases. Moreover, data mining can be also conducted to study the patient's medical history. The analysis predicts potential events, ranging from drug-drug interactions to disease symptoms.
The following software have been analyzed:
Medication analytics is the largest category, and it will also witness the fastest growth during the forecast period, with 9% CAGR. These services leverage data gathered from patients’ EHRs, pharmacy mainframes, and other sources to offer real-time insights into medication compliance and effectiveness. The insights delivered also inform doctors of potential drug allergies and ADRs, which enables the reduction of the risk to patients. Medication analytics also allows for reducing expenses by enabling waste minimization and unnecessary prescriptions. Other benefits of these services are regulatory compliance and support for precision treatment plans.
These services are part of the research scope:
Drive strategic growth with comprehensive market analysis
In 2024, North America accounted for the largest revenue share, of 40%, in the market. This is attributed to the penetration of IT in the medical sector, advanced technological developments, a rise in the prevalence of infectious and chronic diseases, and an increase in the number of prescriptions, in the region.
The U.S. held a larger market share, over 90%, in the region in 2021. This is attributed to high awareness and application of new technologies in health management, the presence of a large number of small to medium-scale players offering administration solutions to various hospitals and pharmacies, and the shortage of primary care physicians in the country. For instance, according to the data published by the Association of American Medical Colleges, the U.S. could see a shortage of 54,100–139,000 physicians by 2033. The shortfall is expected to span both primary- and specialty-care fields.
The APAC market is predicted to grow at the highest rate during the forecast period, of 10.5%. This can be ascribed to the presence of a huge patient pool, rising number of hospitals, improving healthcare infrastructure, and surging medical care expenditure, in the region. Moreover, the growing aging population, increasing demand for mHealth technologies, rising prevalence of chronic diseases, and initiatives taken by government associations to strengthen regulatory norms are other factors driving the demand for medication management software and services in APAC.
The World Economic Forum says that Asia has the largest geriatric population in the world, with Japan, South Korea, and Hong Kong registering the highest numbers in the world. The share of people at least 65 years old is around 30% in Japan, and it will rise to 37.5% by 2050. Similarly, 39.4% of the population of South Korea and 40.6% of Hong Kong will be aged 65 years or older by mid-century.
Moreover, in China, severe respiratory diseases affect around 43 million people, while more than 35 million people have asthma in India. According to the WHO, 173,000 children in Bangladesh and 1 million people in India are moderately burnt each year. Further, 17% of the children with burns in Pakistan and Bangladesh suffer temporary disfiguration, while 18% are disfigured permanently. As per estimates, 19,976,499 people in China had cancer in 2022, while in India, cancer-ridden people numbered 1,413,316.
The regional breakdown of the market is as follows:
Want a report tailored exactly to your business need?
Request CustomizationLeading companies across industries trust us to deliver data-driven insights and innovative solutions for their most critical decisions. From data-driven strategies to actionable insights, we empower the decision-makers who shape industries and define the future. From Fortune 500 companies to innovative startups, we are proud to partner with organisations that drive progress in their industries.
Working with P&S Intelligence and their team was an absolute pleasure – their awareness of timelines and commitment to value greatly contributed to our project's success. Eagerly anticipating future collaborations.
McKinsey & Company
India
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws
Customize the Report to Align with Your Business Objectives
Request the Free Sample Pages